HTFL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Heartflow Inc (HTFL) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows promising growth potential in the AI-based healthcare sector and has a strong analyst rating, the current technical indicators suggest a bearish trend. The stock is oversold, and there are no significant positive catalysts or trading signals to support an immediate buy decision. It may be prudent to monitor the stock for better entry points or wait for further positive developments.
The technical indicators for HTFL are bearish. The MACD is negatively expanding below 0 (-0.716), RSI is at 19.542 indicating an oversold condition, and the moving averages (SMA_200 > SMA_20 > SMA_5) confirm a bearish trend. The stock is trading below key support levels, with S1 at 23.707 and S2 at 21.616.
Wells Fargo initiated coverage with an Overweight rating and a $38 price target, citing strong growth potential in AI-based coronary artery disease diagnosis.
Revenue increased 40.51% YoY in Q3 2025, showing strong business momentum.
No recent news or significant trading trends from hedge funds or insiders.
The stock has a bearish technical setup and is trading below key support levels.
Congress trading data shows no activity in the last 90 days.
In Q3 2025, Heartflow's revenue grew 40.51% YoY to $46.28M, and net income improved significantly to -$50.86M (up 165.70% YoY). EPS increased by 333.33% YoY to -1.04, and gross margin rose slightly to 76.53%. While the company is not yet profitable, its financials show strong growth trends.
Wells Fargo initiated coverage with an Overweight rating and a $38 price target. Analysts expect 20% growth over the next three years, driven by the company's first-mover advantage in AI-based coronary artery disease diagnostics.
